Sugi Predict

Sugi Predict / Compounds / SCHEMBL101069

SCHEMBL101069

SCHEMBL101069

NC(=NO)c1ccccc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 4/20 0.50
▸ GAA P10253 3/20 0.50
▸ LMNA P02545 2/20 0.50
▸ GRIN2B Q13224 1/20 0.50
▸ CES2 O00748 1/20 0.48
▸ CES1 P23141 1/20 0.48
▸ HTT P42858 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ HPGD P15428 3/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ PKM P14618 1/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ NFKB2 Q00653 1/20 0.47
▸ RELA Q04206 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.46
▸ GFER P55789 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ POLB P06746 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL101068 1.00 L3MBTL1 (0.50) L3MBTL1GAALMNAGRIN2BCES2
SCHEMBL10833686 0.98 GRIN2B (0.49) L3MBTL1GAALMNAGRIN2BCES2
SCHEMBL102709 0.83 TSHR (0.50) L3MBTL1GAALMNAGRIN2BRAB9A
SCHEMBL17737959 0.83 TSHR (0.50) L3MBTL1GAALMNAGRIN2BRAB9A
SCHEMBL102710 0.83 TSHR (0.50) L3MBTL1GAALMNAGRIN2BRAB9A
SCHEMBL17730397 0.79 GAA (0.41) L3MBTL1GAALMNAGRIN2BCES2
SCHEMBL17738057 0.79 ALDH1A1 (0.45) L3MBTL1GAALMNAGRIN2BRAB9A
SCHEMBL101736 0.79 ALDH1A1 (0.45) L3MBTL1GAALMNAGRIN2BRAB9A
SCHEMBL17738056 0.79 GAA (0.41) L3MBTL1GAALMNAGRIN2BCES2
SCHEMBL101735 0.79 ALDH1A1 (0.45) L3MBTL1GAALMNAGRIN2BRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3978202-A ο-Chlorobenzamidoxime as an anti-inflammatory agent STAUFFER CHEMICAL COMPANY (US) 1976-08-31 — — US claimed
EP-3215505-B1 PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE Bayer Pharma AG (DE) 2019-07-24 — — EP disclosed
US-10118930-B2 Piperidinylpyrazolopyrimidinones and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-11-06 — — US disclosed
US-20170334917-A1 PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-11-23 — — US disclosed
EP-3215505-A1 PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE Bayer Pharma Aktiengesellschaft (DE) 2017-09-13 — — EP disclosed
WO-2016071216-A1 PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-05-12 — — WO disclosed
WO-2015066371-A1 SPIRO-OXADIAZOLINE COMPOUNDS AS AGONISTS OF α-7-NICOTINIC ACETYLCHOLINE RECEPTORS FORUM PHARMACEUTICALS, INC. (US) 2015-05-07 — — WO disclosed
US-8883826-B2 Alkynyl derivatives as modulators of metabotropic glutamate receptors ADDEX PHARMA SA (CH) 2014-11-11 — — US disclosed
US-8674106-B2 Alkynyl derivatives as modulators of metabotropic glutamate receptors ADDEX PHARMA SA (CH) 2014-03-18 — — US disclosed
US-20130178631-A1 NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA SA (CH) 2013-07-11 — — US disclosed
US-4584317-A FUNGICIDES, MITICIDES CHEVRON RESEARCH COMPANY (US) 1986-04-22 — — US disclosed
WO-1986001800-A1 PESTICIDAL TIN AMIDOXIMES CHEVRON RESEARCH COMPANY (US) 1986-03-27 — — WO disclosed
EP-0036711-B1 PESTICIDAL HETEROCYCLIC COMPOUNDS, PROCESSES FOR PREPARING THEM, COMPOSITIONS CONTAINING THEM, AND THEIR USE FBC LIMITED (GB) 1985-12-04 — — EP disclosed
US-4414221-A MITICIDES, INSECTICIDES, APHIDICIDES FBC LIMITED (GB) 1983-11-08 — — US disclosed
EP-0072905-A1 Bis-oxadiazolyl-naphthalenes, process for their preparation and their application HOECHST AKTIENGESELLSCHAFT (DE) 1983-03-02 — — EP disclosed
EP-0036711-A2 Pesticidal heterocyclic compounds, processes for preparing them, compositions containing them, and their use FBC LIMITED (GB) 1981-09-30 — — EP disclosed
US-3994907-A Coumarin derivatives, their preparation and their use as optical brightening agents PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1976-11-30 — — US disclosed
US-3978202-A ο-Chlorobenzamidoxime as an anti-inflammatory agent STAUFFER CHEMICAL COMPANY (US) 1976-08-31 — — US disclosed
US-3978202-A ο-Chlorobenzamidoxime as an anti-inflammatory agent STAUFFER CHEMICAL COMPANY (US) 1976-08-31 — — US disclosed
US-3978202-A ο-Chlorobenzamidoxime as an anti-inflammatory agent STAUFFER CHEMICAL COMPANY (US) 1976-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178631-A1 NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM5, GRM1, GRM2 L3MBTL1 3907/4885GAA 2330/4885LMNA 4407/4885
US-10118930-B2 Piperidinylpyrazolopyrimidinones and their use HAMP, SERPINC1, PRSS8 L3MBTL1 4443/4885GAA 4335/4885LMNA 2585/4885
US-20170334917-A1 PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE HAMP, SERPINC1, PRSS8 L3MBTL1 4443/4885GAA 4335/4885LMNA 2585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.